Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes

被引：0
|
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, 1 1 5 Sendagi Bunkyo Ku, Tokyo 1138602, Japan
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2023年 / 37卷 / 04期
关键词：
OUTCOMES;
D O I：
10.1007/s10557-022-07374-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：619 / 620
页数：2
相关论文
共 50 条
  • [21] Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
    Yehuda Handelsman
    Advances in Therapy, 2019, 36 : 2567 - 2586
  • [22] Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Yu, Oriana H. Y.
    Chang, Yoosoo
    Cho, Juhee
    Sinn, Dong Hyun
    Cho, Young Min
    Shin, Ju-Young
    GUT, 2023, 72 (05) : 1020 - 1022
  • [23] Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
    Heerspink, Hiddo J. L.
    Kosiborod, Mikhail
    Inzucchi, Silvio E.
    Cherney, David Z. I.
    KIDNEY INTERNATIONAL, 2018, 94 (01) : 26 - 39
  • [24] Sodium-Glucose Cotransporter-2 Inhibitors and Cardiovascular Protection Among Patients With Type 2 Diabetes Mellitus: A Systematic Review
    Yankah, Richard K.
    Anku, Eric K.
    Eligar, Vinay
    JOURNAL OF DIABETES RESEARCH, 2024, 2024
  • [25] Effects of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Glucose Linked coTransporter-2 Inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis
    Savarese, Gianluigi
    D'Amore, Carmen
    Federici, Massimo
    De Martino, Fabiana
    Dellegrottaglie, Santo
    Marciano, Caterina
    Ferrazzano, Francesca
    Losco, Teresa
    Lund, Lars H.
    Trimarco, Bruno
    Rosano, Giuseppe M. C.
    Perrone-Filardi, Pasquale
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 595 - 601
  • [26] Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events
    Nelson, Adam J.
    Harrington, Josephine L.
    Kolkailah, Ahmed A.
    Pagidipati, Neha J.
    McGuire, Darren K.
    HEART FAILURE CLINICS, 2022, 18 (04) : 597 - 607
  • [27] Heterogenous effects of sodium-glucose cotransporter-2 inhibitors on nephrolithiasis in older adults with type 2 diabetes
    Li, Yujia
    Shao, Hui
    Guo, Yi
    Zhang, Yongkang
    Fonseca, Vivian
    Shi, Lizheng
    Bian, Jiang
    Winterstein, Almut G.
    Guo, Serena Jingchuan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 12 - 13
  • [28] Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
    Shapiro, Samantha B.
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (05) : 1365 - 1370
  • [29] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes
    Kramer, Caroline K.
    Zinman, Bernard
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 323 - 334
  • [30] Sodium-glucose Cotransporter-2 Inhibitors and Risk of Hepatocellular Carcinoma Among Patients With Type 2 Diabetes
    Bea, Sungho
    Jeong, Han Eol
    Kim, Jae Hyeon
    Yu, Oriana Hy
    Azoulay, Laurent
    Shin, Ju-Young
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (13) : 3451 - +
12345